TSTickerStarGet alerts

Silo Pharma acquires 'Reputation Endpoints' software and related IP from Larry King in exchange for 150,000 shares

On October 13, 2026, Silo Pharma entered into an asset purchase agreement with Larry King to acquire certain software marketed as 'Reputation Endpoints,' related source code, and assigned intellectual property. In consideration, Silo Pharma issued 150,000 shares of its common stock (par value $0.0001 per share) to Mr. King, with the shares subject to a 12-month lock-up that may end earlier upon a Change in Control or written consent of the Company. The offer and sale was made in reliance on Section 4(a)(2) of th...

Share this story

Key takeaways

  • Asset purchase: Silo Pharma agreed to purchase 'Reputation Endpoints' software (source/object code) and assigned intellectual property from Larry King, with no cash consideration disclosed.

  • Purchase price: 150,000 shares of Silo Pharma common stock issued to Mr. King; no aggregate dollar value disclosed.

  • Lock-up: The 150,000 shares are subject to a 12-month lock-up from the Effective Date, ending earlier upon a Change in Control or written consent of Silo Pharma.

  • Securities exemption: The share issuance was made under Section 4(a)(2) of the Securities Act (unregistered sale).

  • Indemnity cap: Mr. King's aggregate liability under the Agreement is capped at the fair market value of the Purchase Price as of the Effective Date, with representations and warranties surviving for 12 months.

  • Governing law: Agreement is governed by the laws of the State of Florida.

  • Exhibits: Asset Purchase Agreement (Exhibit 10.1) was filed concurrently with this 8-K; Schedules/Exhibits A and B were omitted pursuant to Item 601(b)(10) of Regulation S-K.

Primary source

TickerStar generated this brief from an official company, investor-relations, earnings-call, or regulatory source. Review the primary material before making an investment decision.

Open SEC filing

Follow SILO in real time

Get material earnings, filing, IR, and earnings-call alerts by email.

Create a free alert